INTRODUCTIONTravellers' diarrhoea remains a common problem for those journeying overseas for either business or holidays. It is particularly frequent in visitors to Central America, the Far East, India and parts of Africa. Current estimates are that 60 million travellers from the West visit high risk areas annually, and of these 30±50% have episodes of diarrhoea.
1±7The infecting organisms are very much the same as those that cause acute diarrhoea in both developed and developing countries, e.g. salmonella, shigella, campylobacter, enterotoxigenic and other E. coli, protozoa such as Giardia lamblia and Entamoeba histolytica, and viruses, especially rotavirus.5, 8±11 Of the organisms responsible for travellers' diarrhoea, enterotoxigenic E. coli is by far the most common and is isolated in around 40% of cases. Salmonella and shigella account for a further 25%, followed by giardia and amoeba 15%; the rest are campylobacter, viruses, etc. However, in 20±40% of cases no pathogen is detected. Therefore, of people who get travellers' diarrhoea, around 20% can probably be said to have a cause which is speci®cally targeted at the large intestine. 1,3,10,11 Gastrointestinal infection requires not only an initiating dose of organisms, but also a suitable environment SUMMARY Background: Prebiotic carbohydrates selectively stimulate the growth of bi®dobacteria and lactobacilli in the human colon. These bacteria form part of the gut's inherent defence against invading pathogens. Aim: To test the effectiveness of fructo oligosaccharides in preventing travellers' diarrhoea. Methods: A total of 244 healthy subjects, travelling to high and medium risk destinations for travellers' diarrhoea, took part in a randomized, double-blind, placebo-controlled study. The protocol comprised a preliminary week for recording bowel habit by diary, a 2-week pre-holiday period with the diary and consumption of 10 g of fructo oligosaccharides or placebo daily, followed by a 2-week holiday with continuation of